Andersons pediatric cardiology 1338
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.72 KB, 3 trang )
55.NakayamaM,NawaT,ChonanT,etal.
Prevalenceofpulmonaryarteriovenous
malformationsasestimatedbylow-dosethoracic
CTscreening.InternMed.2012;51(13):1677–
1681.
56.BosherLHJr,BlakeDA,ByrdBR.Ananalysis
ofthepathologicanatomyofpulmonary
arteriovenousaneurysmswithparticular
referencetotheapplicabilityoflocalexcision.
Surgery.1959;45(1):91–104.
57.DinesDE,SewardJB,BernatzPE.Pulmonary
arteriovenousfistulas.MayoClinic
proceedings.1983;58(3):176–181.
58.ShumackerHBJr,WaldhausenJA.Pulmonary
arteriovenousfistulasinchildren.AnnSurg.
1963;158:713–720.
59.TrerotolaSO,PyeritzRE.PAVMembolization:
anupdate.AJRAmJRoentgenol.
2010;195(4):837–845.
60.Dupuis-GirodS,BaillyS,PlauchuH.Hereditary
hemorrhagictelangiectasia:frommolecular
biologytopatientcare.JThrombHaemost.
2010;8(7):1447–1456.
61.GovaniFS,ShovlinCL.Hereditaryhaemorrhagic
telangiectasia:aclinicalandscientificreview.
EurJHumGenet.2009;17(7):860–871.
62.ShovlinCL,GuttmacherAE,BuscariniE,etal.
Diagnosticcriteriaforhereditaryhemorrhagic
telangiectasia(Rendu-Osler-Webersyndrome).
AmJMedGenet.2000;91(1):66–67.
63.DakeishiM,ShioyaT,WadaY,etal.Genetic
epidemiologyofhereditaryhemorrhagic
telangiectasiainalocalcommunityinthe
northernpartofJapan.HumMutat.
2002;19(2):140–148.
64.KjeldsenAD,VaseP,GreenA.Hereditary
haemorrhagictelangiectasia:apopulation-based
studyofprevalenceandmortalityinDanish
patients.JInternMed.1999;245(1):31–39.
65.FaughnanME,PaldaVA,Garcia-TsaoG,etal.
Internationalguidelinesforthediagnosisand
managementofhereditaryhaemorrhagic
telangiectasia.JMedGenet.2011;48(2):73–87.
66.AbdallaSA,LetarteM.Hereditaryhaemorrhagic
telangiectasia:currentviewsongeneticsand
mechanismsofdisease.JMedGenet.
2006;43(2):97–110.
67.vanGentMW,PostMC,SnijderRJ,etal.Real
prevalenceofpulmonaryright-to-leftshunt
accordingtogenotypeinpatientswithhereditary
hemorrhagictelangiectasia:atransthoracic
contrastechocardiographystudy.Chest.
2010;138(4):833–839.
68.ShovlinCL,JacksonJE,BamfordKB,etal.
Primarydeterminantsofischaemicstroke/brain
abscessrisksareindependentofseverityof
pulmonaryarteriovenousmalformationsin
hereditaryhaemorrhagictelangiectasia.Thorax.
2008;63(3):259–266.
69.MahmoudM,AllinsonKR,ZhaiZ,etal.
Pathogenesisofarteriovenousmalformationsin
theabsenceofendoglin.CircRes.
2010;106(8):1425–1433.
70.Field-RidleyA,HeljasvaaraR,PihlajaniemiT,et
al.Endostatin,aninhibitorofangiogenesis,
decreasesafterbidirectionalsuperior
cavopulmonaryanastamosis.PediatrCardiol.
2013;34(2):291–295.
71.KopfGS,LaksH,StanselHC,etal.Thirty-year
follow-upofsuperiorvenacava-pulmonary
artery(Glenn)shunts.JThoracCardiovasc
Surg.1990;100(5):662–670[discussion670661].
72.McElhinneyDB,MarxGR,MarshallAC,Mayer
JE,DelNidoPJ.Cavopulmonarypathway
modificationinpatientswithheterotaxyand
newlydiagnosedorpersistentpulmonary
arteriovenousmalformationsafteramodified
Fontanoperation.JThoracCardiovascSurg.
2011;141(6):1362–1370[e1361].
73.ArrigoniSC,vandenHeuvelF,WillemsTP,et
